100 PHOENIX DRIVE, ANN ARBOR, MI
Shareholder Meeting Results: Eight Directors Elected, Proposals Approved
Earnings Release
Zomedica Records $10.5M Q4 Revenue, $32.0M in 2025, 17% Growth, 68% Margin
Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Announces Second Quarter 2025 Financial Results: Revenue up 14% to $7 Million with 67% Gross Margins and $59 Million in Liquidity to Support Growth
Shareholder votes
Announces First Quarter 2025 Financial Results: Revenue of $6.5 Million; 68% Gross Margin, and $65 Million in Liquidity to Support Growth
Annual Report to Security Holders
Q1
FY 2025
Q3
Q2
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus Filed Pursuant to Rule 425
Prospectus filed pursuant to Rule 424(b)(3)
S-4/A
Definitive Proxy Statement
Additional Proxy Materials
PRE 14A
Statement of Changes in Beneficial Ownership
Registration of Securities under Section 12(g)
Submission Upload
Correspondence
Free Writing Prospectus